Purpose | Protein A/G Sepharose can be used for purification of monoclonal and polyclonal antibodies. |
Characteristics | Protein A/G Sepharose is prepared by covalently coupling recombinant Protein A/G (contains five Ig-binding regions of protein A and three Ig-binding regions of protein G, ABIN412503) to 6 % cross-linked sepharose beads. The coupling was optimized to give a high binding capacity for IgG. The capacity of IgG binding could be greater than 10 mg of human IgG per mL of wet gel. |
ProductDetails: Bead Ligand | Protein A,Protein G |
ProductDetails: Bead Matrix | Sepharose beads |
ProductDetails: Bead Size | 90 μm |
Comment |
Binding capacity greater than 20 mg/ml of wet gel |
Reagent Preparation |
Binding buffer: 0.05 M sodium borate, 0.15 M sodium chloride pH 8.0 |
Assay Procedure |
Procedure Example: |
Restrictions | For Research Use only |
Format | Liquid |
Buffer | Supplied as 50% slurry in 20 % Ethanol/H2O. >1.5mg Protein A/G per ml Sepharose beads |
Handling Advice | Do not freeze! |
Storage | 4 °C |
Expiry Date | 12 months |
Product cited in: |
Zhou, Chen, Arora, Hyams, Kozlowski: "Complement C1 esterase inhibitor levels linked to infections and contaminated heparin-associated adverse events." in: PLoS ONE, Vol. 7, Issue 4, pp. e34978, 2012 (PubMed).
Kundakovic, Chen, Guidotti, Grayson: "The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes." in: Molecular pharmacology, Vol. 75, Issue 2, pp. 342-54, 2009 (PubMed). Dong, Nelson, Grayson, Costa, Guidotti: "Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 36, pp. 13614-9, 2008 (PubMed). |